HEALTHCARE & MEDICARE
    4 hours ago

    Alfasigma pays $300 million for rights to GSK's rare liver disease drug, awaits FDA decision

    GSK has granted Alfasigma global rights to Linerixibat, a treatment for the rare liver disease…
    FRAUD PREVENTION
    7 hours ago

    Mastercard says artificial intelligence and artificial intelligence will be the future of fraud prevention

    Mastercard says artificial intelligence (AI) is fueling “unprecedented” levels of fraud and cybercrime. It may…
    HEALTHCARE & MEDICARE
    8 hours ago

    HIPAA was built for the analog age, and healthcare AI has moved beyond it

    Healthcare AI in the United States has advanced to the point where traditional HIPAA-style compliance…
    HEALTHCARE & MEDICARE
    8 hours ago

    Dialysis is not optional. Neither can transportation.

    NEMT enables dialysis for thousands of patients every day. Should we stop viewing medical transportation…
    HEALTHCARE & MEDICARE
    20 hours ago

    It took Congress several years to enact PBM transparency and decoupling. What about vertical integration?

    Despite recent pharmacy benefit management reforms, the chances of passage of the bipartisan Break Up…
    HEALTHCARE & MEDICARE
    21 hours ago

    Why this rural health system is expanding artificial intelligence for point-of-care decisions

    Presbyterian Healthcare Services has rolled out its AI-powered precision care platform to 200 primary care…
    Social Security
    23 hours ago

    North Carolina Personal Injury: Top 10 Barriers to Recovery

    Unfortunately, simply being injured by another person is not enough to file a North Carolina…
    FRAUD PREVENTION
    1 day ago

    Trump wants Justice Department to prioritize cybercrime cases

    President Donald Trump Hope his administration will crack down on “predatory” schemes targeting American consumers…
    HEALTHCARE & MEDICARE
    1 day ago

    Roche, Zealand Pharma obesity drug meets clinical trial weight loss target, but can it compete?

    Petrelintide released phase 2 results showing it was tolerable as well as placebo, but average…
    HEALTHCARE & MEDICARE
    1 day ago

    Virtual priority care should no longer trigger an “aha” moment

    What Virtual First does well—fully integrated with the electronic medical record, aligned with health system…
      HEALTHCARE & MEDICARE
      4 hours ago

      Alfasigma pays $300 million for rights to GSK's rare liver disease drug, awaits FDA decision

      GSK has granted Alfasigma global rights to Linerixibat, a treatment for the rare liver disease primary biliary cholangitis (PBC). This…
      FRAUD PREVENTION
      7 hours ago

      Mastercard says artificial intelligence and artificial intelligence will be the future of fraud prevention

      Mastercard says artificial intelligence (AI) is fueling “unprecedented” levels of fraud and cybercrime. It may also be one of the…
      HEALTHCARE & MEDICARE
      8 hours ago

      HIPAA was built for the analog age, and healthcare AI has moved beyond it

      Healthcare AI in the United States has advanced to the point where traditional HIPAA-style compliance alone is no longer sufficient.…
      HEALTHCARE & MEDICARE
      8 hours ago

      Dialysis is not optional. Neither can transportation.

      NEMT enables dialysis for thousands of patients every day. Should we stop viewing medical transportation as an afterthought and instead…
      Back to top button